5 Stocks That Should Benefit from the 2026 Medicare Advantage Rate Decision
Briefly

5 Stocks That Should Benefit from the 2026 Medicare Advantage Rate Decision
"The finalized 2.48% increase in Medicare Advantage payment rates injects over $13 billion into private insurers, significantly benefiting 35 million beneficiaries and improving margins for companies like Humana."
"Humana, down 26.09% year to date, saw a 6.99% stock boost following the news, as higher rates directly lift per-member revenue against its cost base."
The Centers for Medicare & Medicaid Services finalized a 2.48% increase in Medicare Advantage payment rates, significantly higher than earlier proposals. This decision injects over $13 billion into private insurers, positively impacting 35 million beneficiaries. Managed care stocks, particularly Humana, experienced a relief rally due to this news. Humana, facing challenges with declining Star Ratings, stands to gain from the higher rates, which will improve its margins and support membership growth. Analysts expect a positive shift in earnings guidance as a result of this rate increase.
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]